6.1. long-term survival primary urethral carcinoma. according rarecare project, one- 5-year relative overall survival (os) rates patients urethral carcinoma europe 71% 54%, respectively . based longer follow-up, analysis seer database, comparing prognostic factors rare pathological types primary urethral carcinoma (n = 257) common pathological groups (n = 2,651), reported 10-year os rates 42.4% 31.9%, respectively . cancer-specific survival (css) rates five ten years 68% 60%, respectively . age (> 60 years), race (others vs. whites), t-stage (t3/t4 vs. taâ€“t2) m-stage (m1 vs. m0) independent prognostic risk factors os css rare pathological variants .